ENLIVEX THERAP.LTD.IS-,01/ IL0011319527 /
| 2024-07-26 8:05:14 AM | Chg. -0.0300 | Volume | Bid9:55:02 PM | Ask9:50:14 PM | High | Low |
|---|---|---|---|---|---|---|
| 1.2500EUR | -2.34% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 1.2500 | 1.2500 |
GlobeNewswire
06-24
Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Tri...
GlobeNewswire
06-20
Join Enlivex Therapeutics’ Chief Executive Officer for a Live Investor Webinar and Q&A Session on Ju...
GlobeNewswire
06-17
Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-...
GlobeNewswire
06-03
Enlivex Receives Regulatory Authorization for the Initiation of a Placebo-Controlled Phase I/II Tria...
GlobeNewswire
04-22
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evalua...
GlobeNewswire
04-16
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Cont...
GlobeNewswire
04-11
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from...
GlobeNewswire
04-11
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsi...
GlobeNewswire
02-07
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Metho...
GlobeNewswire
2023-12-20
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients Wi...
GlobeNewswire
2023-09-11
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
GlobeNewswire
2023-09-07
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire
2022-03-08
Enlivex Announces Issuance of Israeli Patent Covering Allocetra Derived from Pooled Donor Cells
GlobeNewswire
2022-02-22
Enlivex Strengthens Management Team with the Appointment of Biotech Industry Veteran Einat Galamidi,...
GlobeNewswire
2022-01-03
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet N...
GlobeNewswire
2021-12-13
Enlivex Receives Regulatory Authorization to Expand its Phase IIb Trial Evaluating Allocetra in Seve...
GlobeNewswire
2021-12-07
Enlivex Receives Regulatory Authorization to Expand its Phase II Sepsis Trial into Greece
GlobeNewswire
2021-12-06
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Treatment of Sepsis Pa...
GlobeNewswire
2021-11-22
Enlivex Announces Third Quarter 2021 Financial Results and Provides a Business Update
GlobeNewswire
2021-11-10
Spanish Regulator Grants Enlivex Authorization to Expand its Phase IIb Trial Evaluating Allocetra in...
GlobeNewswire
2021-11-04
Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II into Spain
